Champions Oncology Inc - CSBR Net Assets per Single Share

Graphic logo of Champions Oncology (CSBR)

Will service contracts with pharma behemoths ensure sustainable growth for Champions Oncology (CSBR)? The price action of the book value per share and the value of 0.28 reflect the current asset magnitude, although geopolitical tensions and sanctions could hinder the movement of biomaterials. Ultimately, long-term R&D budgets guarantee demand stability, as cancer diagnostics remain independent of economic cycles.

CSBR (Champions Oncology Corp) Accounting Value per Share history from 07/04/2022 to 10/29/2026

Financial and market metric breakdowns for Champions Oncology Inc (CSBR)

- stock price and consensus target price:
Stock Price Champions Oncology Corp|CSBR - Price Target Chart
- issuer market value details:
Market Value Champions Oncology, Inc.|CSBR - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Book Value per Share Champions Oncology|CSBR - Company Net Assets|Market Capitalization to Book Value Ratio championsoncology.com|CSBR - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Equity Champions Oncology|CSBR - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Champions Oncology Corp|CSBR - Company Total Debt|Debts to Book Capitalization Champions Oncology, Inc.|CSBR - Long-Term Debt|Company Short-Term Debt Champions Oncology
Initial company analysis:championsoncology.com (CSBR)
Mass-produced product of Champions Oncology Inc

Finding a balance between asset cost and quality requires analyzing the net equity per share, which determines the level of an investor's asset protection against market drawdowns. For Champions Oncology (CSBR), this metric reflects the value of specialized equipment and biosafety infrastructure, as clearly demonstrated by this book value per share chart.

Main competitors

BeiGene Corp - Book Value per Share|HALO: Net Assets per Single Share|Revolution Medicines (RVMD) - Net Assets per Single Share|ascentage.com - Accounting Value of a Share|CGON (CG Oncology) - Book Value per Share|Accounting Value per Share UroGen Pharma Ltd (URGN)|Book Value per Share BCAX|Book Value per Share Personalis Genomics (PSNL)|Net Assets per Single Share Erasca, Inc. ERAS|DCTH: Equity per Share|Y-mAbs Therapeutics, Inc. - Book Value per Share|Aura Biosciences Inc (AURA) - Accounting Value per Share|CADL: Book Value per Share|Net Asset Value per Share Accuray, Inc. (ARAY)|Net Assets per Single Share SELLAS Life Sciences Group, Inc.|ACTU: Accounting Value of a Share|Accounting Value per Share CTOR (Citius Oncology)|HURA (tuhurabio.com) - Accounting Value of a Share|Book Value per Share TARA (Protara)|FATE - Accounting Value per Share|WHWK: Accounting Value per Share|TCRX - Book Value per Share|xbiotech.com (XBIT) - Net Assets per Single Share|CEL-SCI - Accounting Value of a Share|OSTX (OS Therapies Inc) - Book Value per Share|Net Asset Value per Share radiopharmtheranostics.com RADX|Book Value per Share ARTV|Accounting Value per Share adlainortye.com ANL|Book Value per Share VERU (Veru)|Accounting Value of a Share TPST|Xilio - Book Value per Share|RENB - Book Value per Share|muraloncology.com (MURA) - Net Assets per Single Share|Accounting Value per Share Kairos Pharma|Net Assets per Single Share OnKure Therapeutics, Inc.|CytoMed - Share Book Value|Book Value per Share CRIS|Net Assets per Share apollomicsinc.com|Net Assets per Single Share Tharimmune, Inc. THAR|Advanced Biomed Inc. (ADVB) - Net Asset Value per Share|GNPX - Net Assets per Single Share|CLDI (Calidi Biotherapeutics) - Equity per Share|Sunshine Biopharma, Inc. (SBFM) - Net Assets per Single Share|XBIO - Net Assets per Share|Accounting Value per Share SLRX|PPBT: Accounting Value of a Share|Net Assets per Single Share American Oncology Network (AONC)|BGNE - Net Asset Value per Share|Net Assets per Single Share Checkpoint Therapeutics, Inc CKPT|ELEV: Equity per Share|iCAD Corp - Book Value per Share|Ikena Oncology, Inc. (IKNA) - Accounting Value per Share|Notable Labs (NTBL) - Net Assets per Single Share|Net Asset Value per Share Viracta Therapeutics, Inc. (VIRX)|Net Assets per Single Share MorphoSys Corp|Net Assets per Single Share NAYA|Net Assets per Single Share Ascentage Pharma Group (AAPGV)